Supplemental Table 3 from The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-κB

<p>Supplemental Table 3. Interaction of LY2409881 with other drugs/compounds in two DLBCL cell line.</p>